The agency plans to speed approval of treatments to get them to the market faster, signaling the quickened pace of advancements in this field.
NYS Entity Status
NYS Filing Date
JANUARY 02, 2013
NYS DOS ID#
NYS Entity Type
DOMESTIC BUSINESS CORPORATION
2013 - CLINIC GENE, INC.
Around the Web
- F.D.A. Speeds Review of Gene Therapies, Vowing to Target Rogue Clinics
By SHEILA KAPLAN and DENISE GRADY - Thursday Nov 16, 2017
- In a First, Gene Therapy Halts a Fatal Brain Disease
By GINA KOLATA - Friday Oct 6, 2017
With a disabled AIDS virus, doctors supply a gene to boys with a degenerative neural condition.
- Celgene Builds Up Cancer Drug Pipeline With BeiGene Deal
By Frank Vinluan - Thursday Jul 6, 2017
Celgene wants a shot at a bigger slice of the global cancer drug market, and the company is turning to China to do it. Summit, NJ-based Celgene has reached a deal with BeiGene, based in Beijing, for rights to a cancer immunotherapy still in clinical trials. The deal announced late Wednesday calls for Celgene (NASDAQ: […]
- With $40M for Exonics, Duchenne’s Gene Therapy, CRISPR Race Heats Up
By Ben Fidler - Wednesday Nov 8, 2017
Exonics Therapeutics, one of the players in an emerging race to use gene therapy or gene editing techniques to treat Duchenne muscular dystrophy, has just landed a big round of funding to take its first treatment into clinical testing. The Cambridge, MA, company, seeded last year by a subsidiary of the nonprofit group CureDuchenne, will […]